Trial Outcomes & Findings for Evaluation of an Investigational Multi-Purpose Solution (MPS) (NCT NCT00961051)

NCT ID: NCT00961051

Last Updated: 2014-01-07

Results Overview

Lens cleanliness was assessed by total light reflectance, which is a computerized quantitative assessment conducted in a laboratory. The amount of light that scattered off the lens surface in a light field and was assessed using a light reflectance score that ranged from 0 (maximum lens cleanliness; clean/clear) to100 (minimum lens cleanliness; dirty/opaque).

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

270 participants

Primary outcome timeframe

Day 30

Results posted on

2014-01-07

Participant Flow

Subjects for this study were chosen from the normal hydrogel contact lens-wearing patient populations at each of the investigational sites according to the following inclusion and exclusion criteria.

Participant milestones

Participant milestones
Measure
Investigational MPS
Investigational multipurpose disinfecting solution (study MPS)
Predicate MPS
Opti-Free RepleniSH multipurpose disinfecting solution (predicate MPS)
Overall Study
STARTED
177
93
Overall Study
COMPLETED
165
79
Overall Study
NOT COMPLETED
12
14

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Evaluation of an Investigational Multi-Purpose Solution (MPS)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Investigational MPS
n=177 Participants
Investigational multipurpose disinfecting solution (study MPS)
Predicate MPS
n=93 Participants
Opti-Free RepleniSH multipurpose disinfecting solution (predicate MPS)
Total
n=270 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
177 Participants
n=5 Participants
93 Participants
n=7 Participants
270 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Female
118 Participants
n=5 Participants
65 Participants
n=7 Participants
183 Participants
n=5 Participants
Sex: Female, Male
Male
59 Participants
n=5 Participants
28 Participants
n=7 Participants
87 Participants
n=5 Participants
Region of Enrollment
United States
177 participants
n=5 Participants
93 participants
n=7 Participants
270 participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 30

Population: Lens cleanliness analysis could only be done on subjects whose lenses were returned for analysis. Out of 270 subjects, 253 returned their study lenses to the sponsor for lab analysis (169 + 84 = 253).

Lens cleanliness was assessed by total light reflectance, which is a computerized quantitative assessment conducted in a laboratory. The amount of light that scattered off the lens surface in a light field and was assessed using a light reflectance score that ranged from 0 (maximum lens cleanliness; clean/clear) to100 (minimum lens cleanliness; dirty/opaque).

Outcome measures

Outcome measures
Measure
Investigational MPS
n=169 Participants
Investigational multipurpose disinfecting solution (study MPS)
Predicate MPS
n=84 Participants
Opti-Free RepleniSH multipurpose disinfecting solution (predicate MPS)
Mean Lens Cleanliness as Measured by Light Reflectance
65.5 light reflectance score
Standard Deviation 13.92
66.8 light reflectance score
Standard Deviation 14.95

SECONDARY outcome

Timeframe: Day 180

Corneal staining was performed via slit lamp observation of the corneal through a cobalt blue filter and a yellow #12 or #15 filter Wratten filter following contact lens removal and installation of standard sodium fluorescein.

Outcome measures

Outcome measures
Measure
Investigational MPS
n=165 Participants
Investigational multipurpose disinfecting solution (study MPS)
Predicate MPS
n=79 Participants
Opti-Free RepleniSH multipurpose disinfecting solution (predicate MPS)
Number of Subjects With no Corneal Staining
129 participants
64 participants

Adverse Events

Investigational MPS

Serious events: 0 serious events
Other events: 6 other events
Deaths: 0 deaths

Predicate MPS

Serious events: 0 serious events
Other events: 12 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Investigational MPS
n=177 participants at risk
Investigational multipurpose disinfecting solution (study MPS)
Predicate MPS
n=93 participants at risk
Opti-Free RepleniSH multipurpose disinfecting solution (predicate MPS)
Eye disorders
Red eye
0.56%
1/177 • Number of events 1
2.2%
2/93 • Number of events 2
Eye disorders
Conjunctivitis
1.1%
2/177 • Number of events 2
1.1%
1/93 • Number of events 1
Eye disorders
Corneal infiltrates
0.56%
1/177 • Number of events 1
0.00%
0/93
Eye disorders
Corneal ulcer
0.56%
1/177 • Number of events 1
0.00%
0/93
Eye disorders
Foreign body sensation
0.56%
1/177 • Number of events 1
0.00%
0/93
Eye disorders
Seasonal eye allergies
0.00%
0/177
2.2%
2/93 • Number of events 2
Eye disorders
Keratitis
0.00%
0/177
1.1%
1/93 • Number of events 1
Eye disorders
Superficial punctate keratopathy
0.00%
0/177
1.1%
1/93 • Number of events 1
Eye disorders
Giant papillary conjunctivitis
0.00%
0/177
1.1%
1/93 • Number of events 1
Eye disorders
Recurrent corneal erosion
0.00%
0/177
1.1%
1/93 • Number of events 1
Eye disorders
Hypersensitivity to study solution
0.00%
0/177
2.2%
2/93 • Number of events 2
Eye disorders
Hordeolum
0.00%
0/177
1.1%
1/93 • Number of events 1

Additional Information

Eugenia Thomas, O.D.

Abbott Medical Optics

Phone: 714-247-8723

Results disclosure agreements

  • Principal investigator is a sponsor employee The only disclosure restriction on the PI is that the sponsor can review results communications prior to publication release and can embargo communications regarding trials results for a period that is more than 90 days but less than or equal to 18 months from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
  • Publication restrictions are in place

Restriction type: OTHER